• Publications
  • Influence
Anti‐Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases
Antibodies to the baker's yeast Saccharomyces cerevisiae (ASCA), recently proposed as a serological marker of Crohn's disease, have also been detected in other autoimmune disorders. The aim of thisExpand
  • 75
  • 4
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis
Aims: To evaluate the diagnostic significance of anti-filamentous actin antibodies (A-FAA) assessed with a commercial ELISA in comparison with immunofluorescence reactivity and patterns ofExpand
  • 79
  • 3
The Hepatitic/Cholestatic "Overlap" Syndrome: An Italian Experience
Background: Patients with hepatitic and cholestatic autoimmune liver disease ("overlap syndrome") represent a diagnostic and therapeutic challenge. Aim: To evaluate the prevalence of theExpand
  • 46
  • 2
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.
BACKGROUND Hepatitis C virus (HCV)-related chronic hepatitis is frequently associated with non-organ-specific autoantibodies (NOSAs), but available data about the relationship between NOSA positivityExpand
  • 59
  • 2
Steatosis in chronic hepatitis C.
We read with great interest the review by Asselah et al ( Gut 2006; 55 :123–30) on the relevance of steatosis in chronic hepatitis C. They correctly reported that steatosis occurs more frequently inExpand
  • 31
  • 2
Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim‐like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis
Background  Serum antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim‐like/membranous’ patterns are frequently detected by indirect immunofluorescence on HEp‐2 cells in patientsExpand
  • 28
  • 1
Evidence of a Genetic Basis for the Different Geographic Occurrences of Liver/Kidney Microsomal Antibody Type 1 in Hepatitis C
Antibodies to liver/kidney microsome type 1 occur in Italian patients with hepatitis C, but rarely develop in North American patients. Our goals were to compare the frequencies of the HLA markersExpand
  • 27
Bile duct cell apoptosis is a rare event in primary biliary cirrhosis.
BACKGROUND The frequency of apoptosis in bile duct cells of primary biliary cirrhosis is still unclear spanning from rare to 50% in the various reports. AIM To study bile duct cell apoptosis inExpand
  • 18
Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease.
We read with great interest the paper by Israeli and colleagues ( Gut 2005; 54 :1232–6) assessing the presence of anti- Saccharomyces cerevisiae antibodies (ASCA) and perinuclear antineutrophilExpand
  • 15
Hepatic steatosis in chronic hepatitis C: impact on response to anti‐viral treatment with peg‐interferon and ribavirin
Background:  There is increasing evidence that hepatic steatosis contributes to the progression of liver fibrosis, whereas its impact on the efficacy of anti‐viral treatment is still underExpand
  • 11